Clinical Trial

A Clinical Study of ZL-85FA Tablets

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
An open-label, multicenter phase I/IIa clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZL-85FA tablets in treating advanced solid tumors
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-05.
Trial Details
NCT Number NCT07339748
Lead Sponsor Chengdu Zenitar Biomedical Technology Co., Ltd
Conditions Advanced Solid Tumor
Enrollment 51 participants
Start Date 2026-06-30
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-15